SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: David S. who wrote (3052)12/2/1997 11:39:00 AM
From: Joe E.  Read Replies (1) of 6136
 
<<Gee, I wonder if there were any people who gave a warning MONTHS ago that
Thymitaq was garbage? It is interesting that those who claimed be be the closest to
AGPH management were always the most bullish regarding Thymitaq. Does that
say anything about credibility?>>

David, I will agree you warned me (and I suppose others) on this thread that Thymitaq was not a world beater. i do not recall anything about garbage, though. From the results revealed so far, it looks to me like Thymitaq might have potential with radiation, but it is apparently just too expensive to find out. I think there may be an opportunity for another company to get the rights to the drug and develop it into something good.

Still, I have to say you were right.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext